News

In his new position, Dr Nielsen, a founder of Merrimack who has been with the company since inception, continues to be responsible for the strategic direction of the

A total of $3 million of additional milestone payments from Ovation are pending as a result of the approval of ATryn by the FDA. In addition to the

The abbreviated new drug application approval is the result of an extensive, multi-year development program. Efforts to commercialize the product are now being pursued by Synerx. Ovide lotion

Highlights Pre-tax profits increased 128.3% to GBP6.8m (H1 2008: GBP3 million before potential offer related costs of GBP0.25 million). Product range expanded by 17.3% to 47,870 (31 December

The trial assessed the safety and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a statistically significant clinical benefit in the group receiving BioSeal. The

Teva had indicated it was prepared to launch the generic version prior to the resolution of outstanding patent litigation currently being heard by the US District Court of

Regulus Therapeutics, a biopharmaceutical company, Alnylam Pharmaceuticals, and Isis Pharmaceuticals have announced that Regulus has raised $20m in a series A preferred equity financing. Alnylam and Isis were

As part of this alliance, a team of scientists from Translational Genomics Research Institute (TGen) and Applied Biosystems will employ the SOLiD 3 system, Applied Biosystems’s next-generation genomic

Under the terms of the agreement, Spectral will seek FDA approval for Toraymyxin and intends to commercialize the product together with its endotoxin activity assay (EAA), the only